
Enterome
@enteromesa
Enterome is a clinical-stage biopharmaceutical company developing breakthrough immunomodulatory drugs for the treatment of cancer and inflammatory diseases.
ID: 4717731515
http://www.enterome.com 05-01-2016 19:46:29
488 Tweet
1,1K Followers
344 Following

Many thanks to Labiotech.eu for featuring Enterome's CEO, Pierre Belichard on #BeyondBiotech. Pierre discusses the potential of our #OncoMimics pipeline produced using our Mimicry drug discovery platform & targeting difficult-to-treat cancers (18.13 mins) lnkd.in/dF_js_zs







[Health for Life Capital⢠portfolio] š Congrats! Enterome & Standing Ovation selected, over 840 applicants, as candidates for the investment plan āFrance 2030ā led by the French General Secretary for Investment. #Microbiome #foodscience Isabelle de Cremoux
![Seventure Partners (@seventurep) on Twitter photo [Health for Life Capital⢠portfolio] š Congrats! <a href="/EnteromeSA/">Enterome</a> & <a href="/S_O_Cheese/">Standing Ovation</a> selected, over 840 applicants, as candidates for the investment plan āFrance 2030ā led by the French General Secretary for Investment.
#Microbiome #foodscience <a href="/IdeCremoux/">Isabelle de Cremoux</a> [Health for Life Capital⢠portfolio] š Congrats! <a href="/EnteromeSA/">Enterome</a> & <a href="/S_O_Cheese/">Standing Ovation</a> selected, over 840 applicants, as candidates for the investment plan āFrance 2030ā led by the French General Secretary for Investment.
#Microbiome #foodscience <a href="/IdeCremoux/">Isabelle de Cremoux</a>](https://pbs.twimg.com/media/Fy-K02JWwAM7rHT.png)


"The CLAUDE study (EOCRC1-22; NCT05350501) is the 1st trial to use liquid biopsy monitoring to measure ctDNA clearance as an indicator of OncoMimics⢠immunotherapy efficacy." trial info crcmrd.com/?avada_portfol⦠video with PI Arvind Dasari, MD, MS crcmrd.com/?p=2590



ROSALIE Trial of EO2401/Nivolumab/Bevacizumab in Recurrent Glioblastoma Concludes onclive.com/view/rosalie-t⦠via OncLive.com







